Pfizer Inc. (BCBA:PFE)
Argentina · Delayed Price · Currency is ARS 9,975.00
-75.00 (-0.75%)
Mar 2, 2026, 4:59 PM BRT
Pfizer Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7,771 | 8,031 | 2,119 | 31,372 | 21,979 |
Depreciation & Amortization | 6,554 | 6,994 | 6,258 | 5,028 | 5,104 |
Asset Writedown & Restructuring Costs | 5,308 | 4,261 | 3,440 | 586 | 363 |
Stock-Based Compensation | 799 | 877 | 525 | 872 | 1,182 |
Other Operating Activities | -3,349 | -4,342 | -1,485 | -2,946 | -8,943 |
Change in Accounts Receivable | -263 | -109 | 347 | 261 | -3,811 |
Change in Inventory | 561 | -854 | -1,169 | -591 | -1,125 |
Change in Accounts Payable | -469 | -1,023 | -300 | 1,191 | 1,242 |
Change in Other Net Operating Assets | -5,183 | -1,080 | -1,050 | -6,500 | 16,498 |
Operating Cash Flow | 11,704 | 12,744 | 8,700 | 29,267 | 32,580 |
Operating Cash Flow Growth | -8.16% | 46.48% | -70.27% | -10.17% | 126.20% |
Capital Expenditures | -2,629 | -2,909 | -3,907 | -3,236 | -2,711 |
Cash Acquisitions | -6,927 | - | -43,430 | -22,997 | - |
Investment in Securities | 8,040 | 5,561 | 15,239 | 10,642 | -19,517 |
Other Investing Activities | 165 | - | -180 | -192 | -318 |
Investing Cash Flow | -1,351 | 2,652 | -32,278 | -15,783 | -22,546 |
Short-Term Debt Issued | - | 8,907 | 7,686 | 3,891 | - |
Long-Term Debt Issued | 9,678 | - | 30,831 | - | 997 |
Total Debt Issued | 9,678 | 8,907 | 38,517 | 3,891 | 997 |
Short-Term Debt Repaid | -2,995 | -13,816 | -3 | -4,109 | -96 |
Long-Term Debt Repaid | -6,757 | -2,250 | -2,569 | -3,298 | -2,004 |
Total Debt Repaid | -9,752 | -16,066 | -2,572 | -7,407 | -2,100 |
Net Debt Issued (Repaid) | -74 | -7,159 | 35,945 | -3,516 | -1,103 |
Repurchase of Common Stock | - | - | - | -2,000 | - |
Common Dividends Paid | -9,771 | -9,512 | -9,247 | -8,983 | -8,729 |
Dividends Paid | -9,771 | -9,512 | -9,247 | -8,983 | -8,729 |
Other Financing Activities | -459 | -469 | -632 | -335 | 16 |
Financing Cash Flow | -10,304 | -17,140 | 26,066 | -14,834 | -9,816 |
Foreign Exchange Rate Adjustments | 41 | -66 | -40 | -165 | -59 |
Miscellaneous Cash Flow Adjustments | - | - | 1 | - | - |
Net Cash Flow | 90 | -1,810 | 2,449 | -1,515 | 159 |
Free Cash Flow | 9,075 | 9,835 | 4,793 | 26,031 | 29,869 |
Free Cash Flow Growth | -7.73% | 105.19% | -81.59% | -12.85% | 145.29% |
Free Cash Flow Margin | 14.50% | 15.46% | 8.05% | 25.73% | 36.74% |
Free Cash Flow Per Share | 1.59 | 1.73 | 0.84 | 4.54 | 5.23 |
Cash Interest Paid | 2,739 | 3,227 | 2,215 | 1,442 | 1,467 |
Cash Income Tax Paid | 4,688 | 3,605 | 3,147 | 7,867 | 7,427 |
Levered Free Cash Flow | 13,430 | 12,279 | 1,666 | 25,485 | 30,940 |
Unlevered Free Cash Flow | 15,100 | 14,211 | 3,046 | 26,259 | 31,747 |
Change in Working Capital | -5,354 | -3,066 | -2,172 | -5,639 | 12,804 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.